ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.15
+0.55 (2.67%)
Mar 10, 2026, 1:30 PM CST

ScinoPharm Taiwan Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
3,1104,1663,9424,2954,081
Upgrade
Trading Asset Securities
0.09----
Upgrade
Cash & Short-Term Investments
3,1104,1663,9424,2954,081
Upgrade
Cash Growth
-25.34%5.70%-8.22%5.24%0.64%
Upgrade
Accounts Receivable
612.41633.62788.22635.26360.25
Upgrade
Other Receivables
11.6220.5725.2318.2832.8
Upgrade
Receivables
624.03654.19813.45653.55393.04
Upgrade
Inventory
1,6371,6731,5121,1891,345
Upgrade
Prepaid Expenses
119.99114.91105.79132.2496.85
Upgrade
Other Current Assets
--8.351.1350.71
Upgrade
Total Current Assets
5,4916,6086,3816,3205,967
Upgrade
Property, Plant & Equipment
4,0834,4264,3994,4984,648
Upgrade
Long-Term Investments
1,36870.1369.97112.62185.8
Upgrade
Other Intangible Assets
15.3617.1319.159.958.79
Upgrade
Long-Term Deferred Tax Assets
664.63625.26640.93637.44614.98
Upgrade
Other Long-Term Assets
236.22196.6211.48332.96267.07
Upgrade
Total Assets
11,85811,94311,72211,91111,691
Upgrade
Accounts Payable
62.5382.17102.46126.570.86
Upgrade
Accrued Expenses
-143.45139.78139.6124.62
Upgrade
Short-Term Debt
130.4235.5632.1477.6-
Upgrade
Current Portion of Leases
23.4619.6417.5617.8916.17
Upgrade
Current Income Taxes Payable
14.511.562.699.6471.17
Upgrade
Current Unearned Revenue
115.35119.4110.9767.7570.57
Upgrade
Other Current Liabilities
363.58355.97263.96274.12202.93
Upgrade
Total Current Liabilities
709.84767.68729.45803.09556.31
Upgrade
Long-Term Leases
608.78620.34570.23581.18540.27
Upgrade
Pension & Post-Retirement Benefits
-23.6154.5174.4979.55
Upgrade
Long-Term Deferred Tax Liabilities
0.631.31.66-0.35
Upgrade
Other Long-Term Liabilities
13.743.991.32.363.65
Upgrade
Total Liabilities
1,3331,4171,3571,4611,180
Upgrade
Common Stock
7,9077,9077,9077,9077,907
Upgrade
Additional Paid-In Capital
1,2951,2951,2951,2951,295
Upgrade
Retained Earnings
1,3101,4501,3481,3461,370
Upgrade
Comprehensive Income & Other
12.32-126.18-185.86-98.18-61.13
Upgrade
Shareholders' Equity
10,52510,52610,36410,45010,511
Upgrade
Total Liabilities & Equity
11,85811,94311,72211,91111,691
Upgrade
Total Debt
762.66675.54619.92676.67556.43
Upgrade
Net Cash (Debt)
2,3483,4903,3223,6183,524
Upgrade
Net Cash Growth
-32.75%5.08%-8.19%2.65%1.31%
Upgrade
Net Cash Per Share
2.914.404.194.564.45
Upgrade
Filing Date Shares Outstanding
850.16790.74790.74790.74790.74
Upgrade
Total Common Shares Outstanding
850.16790.74790.74790.74790.74
Upgrade
Working Capital
4,7815,8405,6515,5175,410
Upgrade
Book Value Per Share
12.3813.3113.1113.2213.29
Upgrade
Tangible Book Value
10,50910,50910,34510,44010,502
Upgrade
Tangible Book Value Per Share
12.3613.2913.0813.2013.28
Upgrade
Buildings
-4,3094,2494,0953,546
Upgrade
Machinery
-6,6476,4326,2495,641
Upgrade
Construction In Progress
-194.0477.72155.621,119
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.